0
Editor's Correspondence |

Fondaparinux and Prolonged Thromboprophylaxis After Hip Fracture Surgery—Reply

Bengt I. Eriksson, MD, PhD
Arch Intern Med. 2003;163(22):2790. doi:10.1001/archinte.163.22.2789.
Text Size: A A A
Published online

Extract

In reply

My colleagues and I read with interest the comments of Dr Nurmohamed about the PENTHIFRA-Plus study.1 The importance of the duration of fondaparinux prophylaxis after major orthopedic surgery was first suggested in 4 previous short-term trials, since the efficacy of fondaparinux in preventing VTE was significantly related to the duration of its postoperative administration.2 Furthermore, in the 1-week PENTHIFRA trial in patients undergoing hip fracture surgery, 58.5% of fondaparinux-treated patients in whom a thromboembolic event did not occur received prolonged thromboprophylaxis with the investigators' choice of anticoagulant during follow-up.3 The PENTHIFRA-Plus study was the first trial to evaluate the benefit of extended thromboprophylaxis after hip fracture surgery. The incidence of VTE after 4-week fondaparinux therapy was therefore assumed on the basis of 2 previous long-term prophylaxis trials studying a low-molecular-weight heparin (LMWH) in a lower-risk group of patients undergoing elective hip replacement surgery.4,5 In the first of these trials,4 venography was systematically performed at discharge, and the VTE rate was 13% at the end of 1 week of treatment (31 DVTs in 238 patients). All these patients were excluded from the long-term trial. Four weeks after surgery, there were 6 additional VTEs in the group of patients randomized to long-term thromboprophylaxis with LMWH. If mandatory discharge venography would not have been performed, we can assume that half of the patients with asymptomatic DVT at discharge (ie, 15 patients) would have been enrolled in the group of 119 patients randomized to long-term thromboprophylaxis. Therefore, the total number of VTEs at the end of 4-week thromboprophylaxis would have been 21 (ie, an incidence of 17.6%). In the second long-term prophylaxis trial performed without mandatory discharge venography, the VTE rate at the end of 4-week treatment was also 18%.5 Thus, in patients undergoing total hip replacement surgery with LMWH therapy, the VTE rate increased from 13% at the end of 1-week treatment to 18% at the end of 4-week treatment (ie, a 1.4-fold increase).

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
/>
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles
Jobs
JAMAevidence.com

The Rational Clinical Examination
Clinical Scenario

brightcove.createExperiences();